| 0378-9040 | Mylan Pharmaceuticals Inc. DailyMed label | Mylan Pharmaceuticals Inc. |
| 0378-9040-05 | Mylan Pharmaceuticals Inc. DailyMed label | Mylan Pharmaceuticals Inc. |
| 0378-9045 | Mylan Pharmaceuticals Inc. DailyMed label | Mylan Pharmaceuticals Inc. |
| 0378-9045-05 | Mylan Pharmaceuticals Inc. DailyMed label | Mylan Pharmaceuticals Inc. |
| 42192-121 | Sodium Sulfacetamide 9% - Sulfur 4% Wash In a vehicle containing Green Tea and Aloe Rx Only | ACELLA PHARMACEUTICALS |
| 42192-121-16 | Sodium Sulfacetamide 9% - Sulfur 4% Wash In a vehicle containing Green Tea and Aloe Rx Only | ACELLA PHARMACEUTICALS |
| 54482-020 | These highlights do not include all the information needed to use CYSTARAN ® safely and effectively. See full prescribing information for CYSTARAN. CYSTARAN (cysteamine ophthalmic solution) 0.44%, for topical ophthalmic use Initial U.S. Approval: 1994 | Leadiant Biosciences, Inc. |
| 54482-020-01 | These highlights do not include all the information needed to use CYSTARAN ® safely and effectively. See full prescribing information for CYSTARAN. CYSTARAN (cysteamine ophthalmic solution) 0.44%, for topical ophthalmic use Initial U.S. Approval: 1994 | Leadiant Biosciences, Inc. |
| 54482-020-02 | These highlights do not include all the information needed to use CYSTARAN ® safely and effectively. See full prescribing information for CYSTARAN. CYSTARAN (cysteamine ophthalmic solution) 0.44%, for topical ophthalmic use Initial U.S. Approval: 1994 | Leadiant Biosciences, Inc. |
| 54482-035 | These highlights do not include all the information needed to use CYSTARAN ® safely and effectively. See full prescribing information for CYSTARAN. CYSTARAN (cysteamine ophthalmic solution) 0.44%, for topical ophthalmic use Initial U.S. Approval: 1994 | Leadiant Biosciences, Inc. |
| 54482-035-02 | These highlights do not include all the information needed to use CYSTARAN ® safely and effectively. See full prescribing information for CYSTARAN. CYSTARAN (cysteamine ophthalmic solution) 0.44%, for topical ophthalmic use Initial U.S. Approval: 1994 | Leadiant Biosciences, Inc. |
| 55292-410 | These highlights do not include all the information needed to use CYSTADROPS safely and effectively. See full prescribing information for CYSTADROPS . CYSTADROPS ® (cysteamine ophthalmic solution) 0.37%, for topical ophthalmic use Initial U.S. Approval: 1994 | RECORDATI RARE DISEASES, INC. | Baccinex SA |
| 55292-410-05 | These highlights do not include all the information needed to use CYSTADROPS safely and effectively. See full prescribing information for CYSTADROPS . CYSTADROPS ® (cysteamine ophthalmic solution) 0.37%, for topical ophthalmic use Initial U.S. Approval: 1994 | RECORDATI RARE DISEASES, INC. | Baccinex SA |
| 73309-392 | Cysteamine Hydrochloride | BLUEBAY SHANDONG CO.,LTD |
| 73309-392-01 | Cysteamine Hydrochloride | BLUEBAY SHANDONG CO.,LTD |
| 75987-100 | These highlights do not include all the information needed to use PROCYSBI safely and effectively. See Full Prescribing Information for PROCYSBI. PROCYSBI ® (cysteamine bitartrate) delayed-release capsules, for oral use PROCYSBI ® (cysteamine bitartrate) delayed-release oral granules Initial U.S. Approval: 1994 | Horizon Therapeutics USA, Inc. |
| 75987-100-04 | These highlights do not include all the information needed to use PROCYSBI safely and effectively. See Full Prescribing Information for PROCYSBI. PROCYSBI ® (cysteamine bitartrate) delayed-release capsules, for oral use PROCYSBI ® (cysteamine bitartrate) delayed-release oral granules Initial U.S. Approval: 1994 | Horizon Therapeutics USA, Inc. |
| 75987-101 | These highlights do not include all the information needed to use PROCYSBI safely and effectively. See Full Prescribing Information for PROCYSBI. PROCYSBI ® (cysteamine bitartrate) delayed-release capsules, for oral use PROCYSBI ® (cysteamine bitartrate) delayed-release oral granules Initial U.S. Approval: 1994 | Horizon Therapeutics USA, Inc. |
| 75987-101-08 | These highlights do not include all the information needed to use PROCYSBI safely and effectively. See Full Prescribing Information for PROCYSBI. PROCYSBI ® (cysteamine bitartrate) delayed-release capsules, for oral use PROCYSBI ® (cysteamine bitartrate) delayed-release oral granules Initial U.S. Approval: 1994 | Horizon Therapeutics USA, Inc. |
| 75987-140 | These highlights do not include all the information needed to use PROCYSBI safely and effectively. See Full Prescribing Information for PROCYSBI. PROCYSBI ® (cysteamine bitartrate) delayed-release capsules, for oral use PROCYSBI ® (cysteamine bitartrate) delayed-release oral granules Initial U.S. Approval: 1994 | Horizon Therapeutics USA, Inc. |
| 75987-140-13 | These highlights do not include all the information needed to use PROCYSBI safely and effectively. See Full Prescribing Information for PROCYSBI. PROCYSBI ® (cysteamine bitartrate) delayed-release capsules, for oral use PROCYSBI ® (cysteamine bitartrate) delayed-release oral granules Initial U.S. Approval: 1994 | Horizon Therapeutics USA, Inc. |
| 75987-140-14 | These highlights do not include all the information needed to use PROCYSBI safely and effectively. See Full Prescribing Information for PROCYSBI. PROCYSBI ® (cysteamine bitartrate) delayed-release capsules, for oral use PROCYSBI ® (cysteamine bitartrate) delayed-release oral granules Initial U.S. Approval: 1994 | Horizon Therapeutics USA, Inc. |
| 75987-145 | These highlights do not include all the information needed to use PROCYSBI safely and effectively. See Full Prescribing Information for PROCYSBI. PROCYSBI ® (cysteamine bitartrate) delayed-release capsules, for oral use PROCYSBI ® (cysteamine bitartrate) delayed-release oral granules Initial U.S. Approval: 1994 | Horizon Therapeutics USA, Inc. |
| 75987-145-13 | These highlights do not include all the information needed to use PROCYSBI safely and effectively. See Full Prescribing Information for PROCYSBI. PROCYSBI ® (cysteamine bitartrate) delayed-release capsules, for oral use PROCYSBI ® (cysteamine bitartrate) delayed-release oral granules Initial U.S. Approval: 1994 | Horizon Therapeutics USA, Inc. |
| 75987-145-14 | These highlights do not include all the information needed to use PROCYSBI safely and effectively. See Full Prescribing Information for PROCYSBI. PROCYSBI ® (cysteamine bitartrate) delayed-release capsules, for oral use PROCYSBI ® (cysteamine bitartrate) delayed-release oral granules Initial U.S. Approval: 1994 | Horizon Therapeutics USA, Inc. |